106 results on '"Bolignano, Davide"'
Search Results
2. #770 Urinary PTM3 Fetuin-A in CKD patients with and without diabetic kidney disease
3. #1228 MOTS-c improves CV and mortality risk prediction in chronic hemodialysis patients: a prospective, multicenter cohort study
4. #1037 Urinary marinobufagenin reflects the severity of renal disease in non-advanced CKD: a pilot study
5. Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis.
6. Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis
7. #3101 LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS
8. MO746: Marinobufagenin, Left Ventricular Geometry and Cardiac Dysfunction in End-Stage Kidney Disease Patients
9. MO732: Circulating Omentin-1 and Subclinical Atherosclerosis in Chronic Haemodialysis Patients: A Pilot Study
10. MO753: Marinobufagenin Predicts Intradialytic Hypotension Episodes in Prevalent Haemodialysis Patients
11. Renal safety of catheter-based renal denervation: systematic review and meta-analysis
12. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies
13. Dialysis modality choice in diabetic patients with end-stage kidney disease: a systematic review of the available evidence
14. Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA
15. High versus low dialysate sodium concentration in chronic haemodialysis patients: a systematic review of 23 studies
16. Timing of start of dialysis in diabetes mellitus patients: a systematic literature review*
17. MO728OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY (OCT-A) METRICS PREDICT INTRADIALYTIC HYPOTENSION EPISODES IN CHRONIC HEMODIALYSIS PATIENTS: A PILOT, PROSPECTIVE STUDY
18. MO291RITUXIMAB IS EFFECTIVE AND SAFE IN ADULTS WITH STEROID-DEPENDENT NEPHROTIC SYNDROME: A LONG-TERM, SINGLE-CENTER EXPERIENCE
19. MO791HIGH-SENSITIVITY CARDIAC TROPONIN I CORRELATES WITH THE CARDIAC DYSFUNCTION AND WITH THE SEVERITY OF ANEMIA IN DIALYSIS PATIENTS
20. MO462TIME-TRAJECTORIES OF RENAL FUNCTION AND OUTCOMES IN ELDERLY INDIVIDUALS WITH CKD OF VARIOUS ETIOLOGY
21. MO911ALTERED CIRCULATING OMENTIN-1 LEVELS REFLECT IRON DEFICIENCY IN CHRONIC HEMODIALYSIS PATIENTS
22. MO413EFFECTS OF CHRONIC, LONG-TERM ACE-INHIBITOR TREATMENT ON CYTOKINE STORM AND RENAL FUNCTION AFTER CARDIO-PULMONARY BYPASS: A PROSPECTIVE OBSERVATIONAL STUDY
23. Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)
24. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?
25. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence
26. Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage
27. Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties
28. European Renal Best Practice (ERBP) Guideline development methodology: towards the best possible guidelines
29. Effects of weight loss on renal function in obese CKD patients: a systematic review
30. Management of obesity in kidney transplant candidates and recipients: A clinical practice guideline by the DESCARTES Working Group of ERA.
31. P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS
32. P0806RESIDUAL RENAL FUNCTION IS COMPLEMENTARY TO GERIATRIC ASSESSMENT SCORE IN ASSESSING CLINICAL RISK OF ELDERLY PATIENTS
33. P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS
34. P1317THE PREVALENCE OF CENTRAL VENOUS CATHETERS AND LOWER ARM ARTERIOVENOUS FISTULAS DEPENDS ON DIFFERENT VASCULAR ACCESS MANAGEMENT POLICIES: A MULTICENTER ITALIAN STUDY
35. P0716RAAS INHIBITION MODULATES KYNURENINE LEVELS IN A CKD POPULATION WITH AND WITHOUT TYPE 2 DIABETES MELLITUS
36. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults
37. Neutrophil gelatinase-associated lipocalin (NGAL) reflects iron status in haemodialysis patients
38. Reduction in urinary excretion of neutrophil gelatinase-associated lipocalin by angiotensin receptor blockers in hypertensive patients
39. Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients
40. Erythropoietin and its lost receptor
41. Clinical practice guideline on peri- and postoperative care of arteriovenous fistulas and grafts for haemodialysis in adults
42. FP760COMPARATIVE EFFECTIVENESS OF DIFFERENT ANTIHYPERTENSIVE AGENTS IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS
43. FP420PREVALENCE OF DELIRIUM DIAGNOSIS WITH 4AT AND KIDNEY FUNCTION IN HOSPITALIZED ELDERLY PATIENTS
44. Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis
45. Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.
46. FP369KIDNEY FUNCTION AND COGNITIVE DECLINE IN FRAIL ELDERLY: TWO FACES OF THE SAME COIN?
47. FP333PULMONARY HYPERTENSION AS A RISK FACTOR FOR MORTALITY AND CARDIOVASCULAR EVENTS IN CKD: A SYSTEMATIC REVIEW AND META-ANALYSIS
48. Effect of renin–angiotensin–aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysis
49. SP429ANTIOXIDANT AGENTS FOR DIABETIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
50. SP426SODIUM GLUCOSE COTRANSPORTER-2 SELECTIVE INHIBITORS (SGLT2I) FOR RETARDING DIABETIC KIDNEY DISEASE PROGRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.